Galaxy Securities: the penetration rate of assisted reproduction in China is expected to increase in the future
Galaxy Securities believes that with the introduction of the three child policy and other fertility related policies, the increase of infertility rate and the increase of China's per capita disposable income, the penetration rate of assisted reproduction in China is expected to increase in the future. It is suggested to pay attention to Jinxin reproductive, a high-quality private assisted reproductive institution with technical barriers and license barriers, its acquisition progress and the performance elasticity of the gradual recovery of American business. In addition, we can pay attention to Beikang medical, a leading PGT clinical solution provider in China.
This text is a result of machine translation.
Related companies：
Briefing Jun 20, 2022 04:54 PM
· Technology
The official results of the French parliamentary elections were announced, and the ruling party coalition held a relatively large number of seats
In-depth
Healthcare
Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying
The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?
Feb 21, 2022 02:30 PM
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Briefing Jan 21, 2022 12:19 PM
· Technology
Changchun hi tech: nine directors, supervisors and senior management personnel increased their holdings of 84700 shares in the company
Briefing Jan 20, 2022 02:49 PM
· Technology
Consumer electronics stocks continued to decline
See more
Read next
Insight
In-depth
Insight
In-depth